Repaglinide and Remicade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repaglinide (repaglinide) and Remicade (infliximab). Common drug interactions include bronchitis among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Remicade. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

On Jul, 11, 2026

21 people who take Repaglinide and Remicade together, and have interactions are studied.

Repaglinide and Remicade drug interactions.

What are the common drug interactions of Repaglinide and Remicade, by gender? *:

female:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fatigue (feeling of tiredness)
Hysterectomy
Pneumonia
Renal failure (kidney dysfunction)
Addison's disease (addison's disease, a hormonal disorder disease)
Angioedema (rapid swelling of the dermis)
Arthralgia (joint pain)
Autoimmune hepatitis
Blood pressure increased

male:

Sinusitis (inflammation of sinus)
Cardiac disorder
General physical health deterioration (weak health status)
Hospitalisation
Intestinal resection
Lung neoplasm malignant (cancer tumour of lung)
Mass
Pleural effusion (water on the lungs)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Bladder cancer

What are the common drug interactions of Repaglinide and Remicade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fatigue (feeling of tiredness)
Addison's disease (addison's disease, a hormonal disorder disease)
Angioedema (rapid swelling of the dermis)
Arthralgia (joint pain)
Autoimmune hepatitis
Blood pressure increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest discomfort
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Diarrhoea

40-49:

n/a

50-59:

Citrobacter infection (infection by citrobacter (bacteria))
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Gastrointestinal stenosis (narrowing of gastrointestinal tract)
Hepatic neoplasm malignant (liver cancer)
Mendelson's syndrome (chemical inflammation of lung caused by aspiration during anaesthesia)
Metastatic gastric cancer (cancer types can spread to the stomach from other place)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract)

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Hysterectomy
Pleural effusion (water on the lungs)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Bladder cancer
Colon cancer
Renal failure (kidney dysfunction)
Back pain
Colostomy
Frequent bowel movements

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 38.10%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 19.05%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
Depression: 3 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
Pain: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and Remicade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously